UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 213

Sortiert nach

Development of innate and adaptive immunity to RSV in young children

Cellular immunology, 2024-05, Vol.399-400, p.104824-104824, Article 104824

2024

Link zum Volltext

Verfügbarkeit prüfen

The race to make vaccines for a dangerous respiratory virus

Nature (London), 2021-12, Vol.600 (7889), p.379-380

Powell, Kendall

2021

Link zum Volltext

Verfügbarkeit prüfen

VLPs generated by the fusion of RSV-F or hMPV-F glycoprotein to HIV-Gag show improved immunogenicity and neutralizing response in mice

Vaccine, 2024-05, Vol.42 (15), p.3474-3485

2024

Link zum Volltext

Verfügbarkeit prüfen

A novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent models

PloS one, 2015-03, Vol.10 (3), p.e0119509-e0119509

2015

Link zum Volltext

Verfügbarkeit prüfen

Recombinant live attenuated influenza vaccine viruses carrying CD8 T-cell epitopes of respiratory syncytial virus protect mice against both pathogens without inflammatory disease

Antiviral research, 2019-08, Vol.168, p.9-17

2019

Link zum Volltext

Verfügbarkeit prüfen

Safety and Immunogenicity of the Respiratory Syncytial Virus Vaccine RSV/ΔNS2/Δ1313/I1314L in RSV-Seronegative Children

The Journal of infectious diseases, 2020-06, Vol.222 (1), p.82-91

2020

Link zum Volltext

Verfügbarkeit prüfen

The Number of Respiratory Syncytial Virus (RSV)-Specific Memory CD8 T Cells in the Lung Is Critical for Their Ability to Inhibit RSV Vaccine-Enhanced Pulmonary Eosinophilia

The Journal of immunology (1950), 2008-12, Vol.181 (11), p.7958-7968

2008

Link zum Volltext

Verfügbarkeit prüfen

Respiratory syncytial virus and other respiratory viruses during the first 3 months of life promote a local TH2-like response

Journal of allergy and clinical immunology, 2005-10, Vol.116 (4), p.805-811

2005

Link zum Volltext

Verfügbarkeit prüfen

Development of a Virosomal RSV Vaccine Containing 3D-PHAD® Adjuvant: Formulation, Composition, and Long-Term Stability

Pharmaceutical research, 2018-09, Vol.35 (9), p.172-14, Article 172

2018

Link zum Volltext

Verfügbarkeit prüfen

HRSV prefusion-F protein with Adju-Phos adjuvant induces long-lasting Th2-biased immunity in mice

PloS one, 2022-01, Vol.17 (1), p.e0262231-e0262231

2022

Link zum Volltext

Verfügbarkeit prüfen

Two RSV Platforms for G, F, or G+F Proteins VLPs

Viruses, 2020-08, Vol.12 (9), p.906

2020

Link zum Volltext

Verfügbarkeit prüfen

Intranasal immunization with W 80 5EC adjuvanted recombinant RSV rF-ptn enhances clearance of respiratory syncytial virus in a mouse model

Human vaccines & immunotherapeutics, 2014, Vol.10 (3), p.615-622

2014

Link zum Volltext

Verfügbarkeit prüfen

Phenotype and Hierarchy of Two Transgenic T Cell Lines Targeting the Respiratory Syncytial Virus KdM282-90 Epitope Is Transfer Dose-Dependent

PloS one, 2016, Vol.11 (1), p.e0146781-e0146781

2016

Link zum Volltext

Verfügbarkeit prüfen

Infection with respiratory syncytial virus influences FasL-mediated apoptosis of pulmonary γδ T cells in a murine model of allergen sensitization

The Journal of asthma, 2014-05, Vol.51 (4), p.360-365

2014

Link zum Volltext

Verfügbarkeit prüfen

The beta2 integrin CD11c distinguishes a subset of cytotoxic pulmonary T cells with potent antiviral effects in vitro and in vivo

Respiratory research, 2005-07, Vol.6 (1), p.70-70, Article 70

2005

Link zum Volltext

Verfügbarkeit prüfen

Signaling through the Prostaglandin I2 Receptor IP Protects against Respiratory Syncytial Virus-Induced Illness

Journal of Virology, 2004-10, Vol.78 (19), p.10303-10309

2004

Link zum Volltext

Verfügbarkeit prüfen

A Respiratory Syncytial Virus (RSV) Anti-G Protein F(ab′)2 Monoclonal Antibody Suppresses Mucous Production and Breathing Effort in RSV rA2-line19F-Infected BALB/c Mice

Journal of Virology, 2013-10, Vol.87 (20), p.10955-10967

2013

Link zum Volltext

Verfügbarkeit prüfen

RSV respiratory infection in children under 5 y.o.--dynamics of the immune response Th1/Th2 and IgE

Przegląd epidemiologiczny, 2013, Vol.67 (1), p.17

2013

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis B Virus Core Particles Containing a Conserved Region of the G Protein Combined with Interleukin-35 Protected Mice against Respiratory Syncytial Virus Infection without Vaccine-Enhanced Immunopathology

Journal of virology, 2020-06, Vol.94 (13)

2020

Link zum Volltext

Verfügbarkeit prüfen

Correlation between the numbers of peripheral blood dendritic cells and the clinical manifestations in children with respiratory syncytial virus bronchiolitis

Xi bao yu fen zi mian yi xue za zhi, 2013-07, Vol.29 (7), p.748

2013

Link zum Volltext

Verfügbarkeit prüfen

Airway T cells protect against RSV infection in the absence of antibody

Mucosal immunology, 2018-01, Vol.11 (1), p.249-256

2018

Link zum Volltext

Verfügbarkeit prüfen

Changes and the clinical significance of CD4⁺ CD25⁺ regulatory T cells and Th17 cells in peripheral blood of infants with respiratory syncytial virus bronchiolitis

Xi bao yu fen zi mian yi xue za zhi, 2012-04, Vol.28 (4), p.426

2012

Link zum Volltext

Verfügbarkeit prüfen

The Attachment (G) Glycoprotein of Respiratory Syncytial Virus Contains a Single Immunodominant Epitope That Elicits Both Th1 and Th2 CD4+ T Cell Responses

The Journal of immunology (1950), 2000-12, Vol.165 (11), p.6487-6495

2000

Link zum Volltext

Verfügbarkeit prüfen

Enhanced IL-2 in early life limits the development of TFH and protective antiviral immunity

The Journal of experimental medicine, 2021-12, Vol.218 (12)

2021

Link zum Volltext

Verfügbarkeit prüfen

T - helper2 /T - helper1 imbalance in respiratory syncytial virus bronchiolitis in relation to disease severity and outcome

The Egyptian journal of immunology, 2008, Vol.15 (2), p.153

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 213

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(153)
Mit Volltextzugriff
(122)

Publikationsform

Artikel
(209)
magazinearticle
(4)

Sprache

10 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(155)
Male
(132)
Respiratory Syncytial Viruses - Immunology
(109)
Infant
(94)
Animals
(79)
Respiratory Syncytial Virus Infections - Immunology
(79)
Child, Preschool
(77)
Respiratory Syncytial Virus
(63)
Child
(52)
Mice
(47)
Infant, Newborn
(45)
Mice, Inbred Balb C
(41)
Biological And Medical Sciences
(38)
Adult
(35)
Antibodies, Viral - Analysis
(32)
Adolescent
(31)
Respiratory Tract Infections - Immunology
(31)
Respiratory Syncytial Virus Infections - Prevention & Control
(28)
Respiratory Syncytial Virus Infections - Virology
(28)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Development of innate and adaptive immunity to RSV in young children

The race to make vaccines for a dangerous respiratory virus

VLPs generated by the fusion of RSV-F or hMPV-F glycoprotein to HIV-Gag show improved immunogenicity and neutralizing response in mice

A novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent models

Recombinant live attenuated influenza vaccine viruses carrying CD8 T-cell epitopes of respiratory syncytial virus protect mice against both pathogens without inflammatory disease

Safety and Immunogenicity of the Respiratory Syncytial Virus Vaccine RSV/ΔNS2/Δ1313/I1314L in RSV-Seronegative Children

The Number of Respiratory Syncytial Virus (RSV)-Specific Memory CD8 T Cells in the Lung Is Critical for Their Ability to Inhibit RSV Vaccine-Enhanced Pulmonary Eosinophilia

Respiratory syncytial virus and other respiratory viruses during the first 3 months of life promote a local TH2-like response

Development of a Virosomal RSV Vaccine Containing 3D-PHAD® Adjuvant: Formulation, Composition, and Long-Term Stability

HRSV prefusion-F protein with Adju-Phos adjuvant induces long-lasting Th2-biased immunity in mice

Two RSV Platforms for G, F, or G+F Proteins VLPs

Intranasal immunization with W 80 5EC adjuvanted recombinant RSV rF-ptn enhances clearance of respiratory syncytial virus in a mouse model

Phenotype and Hierarchy of Two Transgenic T Cell Lines Targeting the Respiratory Syncytial Virus KdM282-90 Epitope Is Transfer Dose-Dependent

Infection with respiratory syncytial virus influences FasL-mediated apoptosis of pulmonary γδ T cells in a murine model of allergen sensitization

The beta2 integrin CD11c distinguishes a subset of cytotoxic pulmonary T cells with potent antiviral effects in vitro and in vivo

Signaling through the Prostaglandin I2 Receptor IP Protects against Respiratory Syncytial Virus-Induced Illness

A Respiratory Syncytial Virus (RSV) Anti-G Protein F(ab′)2 Monoclonal Antibody Suppresses Mucous Production and Breathing Effort in RSV rA2-line19F-Infected BALB/c Mice

RSV respiratory infection in children under 5 y.o.--dynamics of the immune response Th1/Th2 and IgE

Hepatitis B Virus Core Particles Containing a Conserved Region of the G Protein Combined with Interleukin-35 Protected Mice against Respiratory Syncytial Virus Infection without Vaccine-Enhanced Immunopathology

Correlation between the numbers of peripheral blood dendritic cells and the clinical manifestations in children with respiratory syncytial virus bronchiolitis

Airway T cells protect against RSV infection in the absence of antibody

Changes and the clinical significance of CD4⁺ CD25⁺ regulatory T cells and Th17 cells in peripheral blood of infants with respiratory syncytial virus bronchiolitis

The Attachment (G) Glycoprotein of Respiratory Syncytial Virus Contains a Single Immunodominant Epitope That Elicits Both Th1 and Th2 CD4+ T Cell Responses

Enhanced IL-2 in early life limits the development of TFH and protective antiviral immunity

T - helper2 /T - helper1 imbalance in respiratory syncytial virus bronchiolitis in relation to disease severity and outcome

Aktive Filter

Suchergebnisse filtern